Limites du sumatriptan dans le traitement des céphalées après ponction de la dure-mère

Annales Francaises d'Anesthesie et de Reanimation

Volumn 15, Issue 2, 1996, Pages 229-230

  Von Hornstein, W Freiherr ^a   Reich, A ^b  

^a Klin Tumorbiologie An Albert L   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; SUFENTANIL; SUMATRIPTAN;

ADULT; CASE REPORT; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; LETTER; LUMBAR PUNCTURE; REGIONAL ANESTHESIA;

ADULT; ANESTHESIA, EPIDURAL; ANESTHESIA, OBSTETRICAL; BLOOD PATCH, EPIDURAL; DURA MATER; FEMALE; HEADACHE; HUMANS; PREGNANCY; SUMATRIPTAN; TREATMENT FAILURE; VASOCONSTRICTOR AGENTS;

EID: 0005839538     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/0750-7658(96)85056-8     Document Type: Article

References (5)

1. Rohmer C, Le Bourlot G. Céphalées après rachianesthésie traitées par le sumatriptan [lettre], Ann Fr Anesth Réanim 1995;14:237
2. Carp H, Singh PJ, Vadhera R, Jayaram A. Effects of the serotinin-receptor agonist sumatriptan on postdural puncture headache: report of six cases. Anesth Analg 1994;79:180-2
3. Baumgarten RK. Should caffeine become the first-line treatment for postdural puncture headache ? [letter]. Anesth Analg 1987;66:913-4
4. Jarvis AP, Greenawalt JW, Fagraeus L. Intravenous caffeine for postdural puncture headache [Letter]. Anesth Analg 1986;65:316-7
5. Brown DL. Spinal, epidural, and caudal anesthesia. In: Miller RD, ed. Anesthesia. 4th ed. New York: Churchill Livingstone, 1994:1505-33